A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming into Clinical Practice
暂无分享,去创建一个
Jason M Glanz | Shane R Mueller | Ingrid A Binswanger | J. Glanz | Shane R. Mueller | S. Calcaterra | I. Binswanger | Alexander Y Walley | A. Walley | Susan L Calcaterra
[1] L. Paulozzi. Drug-induced deaths - United States, 2003-2007. , 2011, MMWR supplements.
[2] Leonard J. Paulozzi,et al. Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008. , 2011, MMWR. Morbidity and mortality weekly report.
[3] M. Stein,et al. Overdoses among friends: drug users are willing to administer naloxone to others. , 2006, Journal of substance abuse treatment.
[4] K. Seal,et al. Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area , 2003, Journal of Urban Health.
[5] Christopher Welsh,et al. "The life they save may be mine": diffusion of overdose prevention information from a city sponsored programme. , 2009, The International journal on drug policy.
[6] S. Wakeman,et al. Preventing Death Among the Recently Incarcerated: An Argument for Naloxone Prescription Before Release , 2009, Journal of addictive diseases.
[7] K. Seal,et al. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: A pilot intervention study , 2005, Journal of Urban Health.
[8] T. M. Piper,et al. Overdose prevention for injection drug users: Lessons learned from naloxone training and distribution programs in New York City , 2007, Harm reduction journal.
[9] Susan Okie,et al. A flood of opioids, a rising tide of deaths. , 2010, The New England journal of medicine.
[10] J. Rich,et al. Physicians’ Knowledge of and Willingness to Prescribe Naloxone to Reverse Accidental Opiate Overdose: Challenges and Opportunities , 2006, Journal of Urban Health.
[11] J. Rich,et al. Prevention of fatal opioid overdose. , 2012, JAMA.
[12] T. Valente,et al. Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA. , 2010, The International journal on drug policy.
[13] R. Heimer,et al. Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States. , 2008, Addiction.
[14] S. Lenton,et al. Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond. , 2015, Drug and alcohol review.
[15] T. Bennett,et al. The impact of take-home naloxone distribution and training on opiate overdose knowledge and response: An evaluation of the THN Project in Wales , 2011 .
[16] K. Mills,et al. Rates and correlates of mortality amongst heroin users: findings from the Australian Treatment Outcome Study (ATOS), 2001-2009. , 2011, Drug and alcohol dependence.
[17] Sanju George,et al. A Guide for Clinicians on “Take Home” Naloxone Prescribing , 2008 .
[18] S. Stancliff,et al. Providing Naloxone to Substance Users for Secondary Administration to Reduce Overdose Mortality in New York City , 2007, Public health reports.
[19] T. S. Jones,et al. Community-based opioid overdose prevention programs providing naloxone - United States, 2010. , 2012, MMWR. Morbidity and mortality weekly report.
[20] L. Paulozzi,et al. Mental illness and psychotropic drug use among prescription drug overdose deaths: a medical examiner chart review. , 2010, The Journal of clinical psychiatry.
[21] J. Strang,et al. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study , 2003, BMJ : British Medical Journal.
[22] A. Orkin,et al. Development and Implementation of an Opioid Overdose Prevention and Response Program in Toronto, Ontario , 2013, Canadian Journal of Public Health.
[23] C. Taylor,et al. Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability. , 1999, Addiction.
[24] J. Elmore,et al. Release from prison--a high risk of death for former inmates. , 2007, The New England journal of medicine.
[25] Alex H. Kral,et al. Overdose Prevention and Naloxone Prescription for Opioid Users in San Francisco , 2010, Journal of Urban Health.
[26] S. Sullivan,et al. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal in Russian cities , 2013, Journal of medical economics.
[27] N. Dasgupta,et al. Opioid Drug Overdoses: A Prescription for Harm and Potential for Prevention , 2010 .
[28] H. Surratt,et al. Effect of abuse-deterrent formulation of OxyContin. , 2012, The New England journal of medicine.
[29] T. M. Piper,et al. Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City. , 2006, Addictive behaviors.
[30] K. Khoshnood,et al. Expanded access to naloxone: options for critical response to the epidemic of opioid overdose mortality. , 2009, American journal of public health.
[31] A. Kelly,et al. Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose , 2005, The Medical journal of Australia.
[32] W. Hall,et al. Heroin overdose: causes and consequences. , 2001, Addiction.
[33] S. Burris,et al. Stopping an Invisible Epidemic: Legal Issues in the Provision of Naloxone to Prevent Opioid Overdose , 2009 .
[34] Christopher M. Jones,et al. Vital signs: risk for overdose from methadone used for pain relief - United States, 1999-2010. , 2012, MMWR. Morbidity and mortality weekly report.
[35] C. Semmler,et al. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. , 2008, Addiction.
[36] A. Kelly,et al. Intranasal naloxone for the treatment of suspected heroin overdose. , 2008, Addiction.
[37] N. Loimer,et al. Nasal administration of naloxone is as effective as the intravenous route in opiate addicts. , 1994, The International journal of the addictions.
[38] A. McAuley,et al. Responsible management and use of a personal take-home naloxone supply: A pilot project , 2009 .
[39] W. Hall,et al. The distribution of naloxone to heroin users. , 1997, Addiction.
[40] R. Heimer,et al. A qualitative study of overdose responses among Chicago IDUs , 2008, Harm reduction journal.
[41] D. Jolley,et al. Attitudes of Australian Heroin Users to Peer Distribution of Naloxone for Heroin Overdose: Perspectives on Intranasal Administration , 2008, Journal of Urban Health.
[42] Al Ozonoff,et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis , 2013, BMJ.
[43] J. Buxton,et al. A quantitative and qualitative evaluation of the British Columbia Take Home Naloxone program. , 2014, CMAJ open.
[44] Li Hui Chen,et al. Drug poisoning deaths in the United States, 1980-2008. , 2011, NCHS data brief.
[45] C. Matheson,et al. Reducing drug related deaths: a pre-implementation assessment of knowledge,barriers and enablers for naloxone distribution through general practice , 2014, BMC Family Practice.
[46] Matthew D. Saybolt,et al. Intranasal naloxone delivery is an alternative to intravenous naloxone for opioid overdoses. , 2010, The American journal of emergency medicine.
[47] R. Heimer,et al. Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997-2007. , 2011, Drug and alcohol dependence.
[48] J. Ioannidis,et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. , 2009, Journal of clinical epidemiology.
[49] J. Havens,et al. Individual and network factors associated with non-fatal overdose among rural Appalachian drug users. , 2011, Drug and alcohol dependence.
[50] Karin A Mack,et al. Pharmaceutical overdose deaths, United States, 2010. , 2013, JAMA.
[51] J. Strang,et al. Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes , 2001, BMJ : British Medical Journal.
[52] S. B. Leavitt. Intranasal Naloxone for , 2010 .
[53] R. Heimer,et al. Barriers to Medical Provider Support for Prescription Naloxone As Overdose Antidote for Lay Responders , 2013, Substance use & misuse.
[54] S. Galea,et al. Identifying injection drug users at risk of nonfatal overdose. , 2007, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[55] E. Mackenzie,et al. Attitudes of emergency medical service providers toward naloxone distribution programs , 2005, Journal of Urban Health.
[56] C. Baca,et al. What Heroin Users Tell Us About Overdose , 2007, Journal of addictive diseases.
[57] S. Galea,et al. Characteristics of drug users who witness many overdoses: implications for overdose prevention. , 2012, Drug and alcohol dependence.
[58] J. Glanz,et al. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. , 2013, Drug and alcohol dependence.
[59] I. Buajordet,et al. Adverse events after naloxone treatment of episodes of suspected acute opioid overdose , 2004, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.
[60] K. Sporer. Acute Heroin Overdose , 1999, Annals of Internal Medicine.
[61] W. Hall,et al. Heroin overdose: Research and evidence-based intervention , 2003, Journal of Urban Health.
[62] J. Strang,et al. Emergency naloxone for heroin overdose , 2006, British medical journal.
[63] Yongli Xi,et al. Increasing deaths from opioid analgesics in the United States , 2006, Pharmacoepidemiology and drug safety.
[64] C. Latkin,et al. Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives. , 2009, The International journal on drug policy.
[65] T. Green,et al. Opioid overdose prevention and naloxone distribution in Rhode Island. , 2011, Medicine and health, Rhode Island.
[66] J. Steiner,et al. Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors , 2012, Addiction Science & Clinical Practice.
[67] Nabarun Dasgupta,et al. Project Lazarus: community-based overdose prevention in rural North Carolina. , 2011, Pain medicine.
[68] D. Jolley,et al. Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. , 2009, Addiction.
[69] Alex H. Kral,et al. Characteristics of an Overdose Prevention, Response, and Naloxone Distribution Program in Pittsburgh and Allegheny County, Pennsylvania , 2011, Journal of Urban Health.
[70] Al Ozonoff,et al. Opioid overdose prevention with intranasal naloxone among people who take methadone. , 2013, Journal of substance abuse treatment.
[71] Sean D. Sullivan,et al. Cost-Effectiveness of Distributing Naloxone to Heroin Users for Lay Overdose Reversal , 2013, Annals of Internal Medicine.
[72] J. Hahn,et al. Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study. , 2012, American journal of epidemiology.
[73] R. Hoffman,et al. Testing positive for methadone and either a tricyclic antidepressant or a benzodiazepine is associated with an accidental overdose death: analysis of medical examiner data. , 2006, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[74] S. Galea,et al. Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City , 2003, Journal of Urban Health.
[75] Sarz Maxwell,et al. Prescribing Naloxone to Actively Injecting Heroin Users , 2006, Journal of addictive diseases.
[76] Leonard J Paulozzi,et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. , 2008, JAMA.
[77] B. Psaty,et al. Opioid Prescriptions for Chronic Pain and Overdose , 2010, Annals of Internal Medicine.
[78] P. Friedmann,et al. Revisiting Paulozzi et al.'s "Prescription drug monitoring programs and death rates from drug overdose". , 2011, Pain medicine.
[79] S. Galea,et al. Opiate users' knowledge about overdose prevention and naloxone in New York City: a focus group study , 2006, Harm reduction journal.
[80] T. Wolfe,et al. Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting. , 2005, The Journal of emergency medicine.
[81] T. M. Piper,et al. Evaluation of a Naloxone Distribution and Administration Program in New York City , 2008, Substance use & misuse.
[82] S. McDonald,et al. Cognitive impairment among methadone maintenance patients. , 2000, Addiction.
[83] D. Wermeling. Opioid Harm Reduction Strategies: Focus on Expanded Access to Intranasal Naloxone , 2010, Pharmacotherapy.
[84] A. Håkansson,et al. Utdelning av naloxon för att förebygga död i heroinöverdos. Studie av opiatberoende patienters attityder till att ingå i antidotprogram. , 2013 .
[85] S. Burris,et al. Changing Law from Barrier to Facilitator of Opioid Overdose Prevention , 2013, The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics.
[86] P. Moyer,et al. Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. , 2009, American journal of public health.
[87] J. Rich,et al. Preventing Opiate Overdose Deaths: Examining Objections to Take-Home Naloxone , 2010, Journal of health care for the poor and underserved.
[88] M. Valenstein,et al. Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths , 2012 .
[89] N. Wright,et al. Homeless drug users' awareness and risk perception of peer "Take Home Naloxone" use – a qualitative study , 2006, Substance abuse treatment, prevention, and policy.
[90] D. Best,et al. Can we prevent drug related deaths by training opioid users to recognise and manage overdoses? , 2009, Harm reduction journal.
[91] K. Wagner,et al. Injection Drug Users Trained by Overdose Prevention Programs: Responses to Witnessed Overdoses , 2013, Journal of Community Health.